At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
HyperSperm +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients
In Brief
A clinical study evaluating HyperSperm and Standard Sperm Preparation for Infertility. Completed, enrolled 41 participants across 4 sites.
Detailed Summary
Prospective, multi-centric, split-sample, sibling oocyte study evaluating the safety and efficacy of a new method to prepare sperm samples for IVF (in vitro fertilization) / ICSI (intracytoplasmic sperm injection) compared to standard procedures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesArgentina
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJan 2023
Enrollment StartMay 2023
Primary CompletionDec 2025
TodayJul 2026
First PostedJan 11, 2023
Enrollment StartMay 1, 2023
Primary CompletionDec 18, 2025
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 3.5 years ago
Interventions
HyperSpermdevice
Multi-step sperm preparation
Standard Sperm Preparationdevice
Standard sperm preparation